REQUEST A DEMO
Total
USD $0.00
Search more companies

CLC Pharma Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: CLC Pharma Kft. Profile Updated: July 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

CLC Pharma Kft. is based in Hungary. The head office is in Madaras. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was first established on July 28, 1994. The company’s latest financial report indicates a net sales revenue increase of 19.71% in 2025. A negative growth of 47.71% was recorded in its total assets. In 2025, CLC Pharma Kft.’s net profit margin decreased by 2.96%.

Headquarters
Zsambeki ut 220/1.
Madaras; Bacs-Kiskun; Postal Code: 2053

Contact Details: Purchase the CLC Pharma Kft. report to view the information.

Basic Information
Registered Capital:
Purchase the CLC Pharma Kft. report to view the information.
Financial Auditors:
Purchase the CLC Pharma Kft. report to view the information.
Incorporation Date:
July 28, 1994
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after CLC Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
19.71%
Total Operating Revenue
19.56%
Operating Profit
13.63%
EBITDA
13.86%
Net Profit/Loss for the Period
-17.3%
Total Assets
-47.71%
Total Equity
30.85%
Operating Profit Margin
-0.5%
Net Profit Margin
-2.96%
Return on Equity (ROE)
-13.73%
Debt / Equity
-14.1%
Quick Ratio
0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?